Business StandardCenter·
Sebi warns Dabur India over delay in disclosing USFDA warning letter
The market regulator has cautioned Dabur India over delayed disclosure of a USFDA warning letter, saying repeated violations could attract enforcement action under Sebi rules.
Read at Business Standard →

